EU Industry Benchmark
Pharma
Anonymized security posture data for the pharma sector across the EU. Based on 13791 monitored sites.
44.2
Avg. Score /100
D
Avg. Grade
13791
Sites Tracked
+2.0
vs. EU Average
Critical findings in this industry
12591 of 13791 without HTTPS redirect
9247 of 13791 with unencrypted email (no STARTTLS)
11347 of 13791 without DMARC protection (spoofable)
1415 of 13791 missing 3+ critical security headers
12424 of 13791 without DNSSEC (vulnerable to DNS spoofing)
13510 of 13791 without CAA records (unrestricted certificate issuance)
13735 of 13791 without MTA-STS (email downgrade attacks possible)
Grade Distribution
Security across Europe
Average security score by country — hover for details, click to explore.
/100 · sites
Score by Country
Hosting & Data Residency
51%
EU-headquartered provider
49%
Non-EU provider (CLOUD Act / Schrems II)
Server location via IP geolocation (MaxMind GeoLite2). Company HQ from ASN registry. A site may be physically hosted in the EU but use a US-headquartered provider subject to the CLOUD Act — per Schrems II (CJEU C-311/18), this requires SCCs with supplementary measures. · GDPR Art. 44–49
All data is anonymized. No individual sites are identified. Statistics updated weekly.